MAQC Society’s 2022 SEQC2 Webinar Series – Advancing quality-control for NGS measurement of actionable mutations in circulating tumor DNA

Date & Time 5 April 2022 at 17:00-18:00 CEST
Location Virtual

The MAQC Society is pleased to announce a new series of SEQC2 (Sequencing and Quality Control Phase 2) Webinars addressing the many challenges of analysis of massive datasets that come from Next-Gen Sequencing (NGS).  This year, in 2022, MAQC offers a new webinar series on diverse topics related to NGS:  copy-number pathogenicity, structural variation detection, use of internal standards and synthetic controls for variant detection, formalin-fixation impacts, and general reproducibility challenges.

On 5 April the webinar is titled: “Advancing quality-control for NGS measurement of actionable mutations in circulating tumor DNA” by Dr James C. Willey Ph. D., George Isaac Chair for Cancer Research.

Here is a short introduction by Dr Willey:

“I am currently Professor of Medicine and Pathology, and George Isaac Chair for Cancer Research with more than 25 years of continuous funding from the National Institutes of Health in translational research. We develop methods to optimise quality control in next generation sequencing analysis of germline and somatic variants in clinical specimens, including circulating tumour DNA. Since 2005, my laboratory has participated in the United States Food and Drug Administration (FDA) MAQC collaborative projects to improve quality control in genetic testing. Through these FDA consortia, as of 2021, I have co-authored twelve articles reporting results from these collaborative projects, including nine in Nature Biotechnology articles, three Genome Biology, and one in Cell Reports Methods.”

Check out the other 5 webinars as well:

Read more here. Free registration for the webinars is open here.